Capricor to present 24-month HOPE-3 and OLE Deramiocel results

Capricor Therapeutics will present 24-month HOPE-3 and OLE Deramiocel results, with 82 of 106 patients reaching 24 months (40 treated, 42 placebo), plus preclinical StealthX exosome posters at WMS 2026 ahead of a Nov 22, 2026 PDUFA date.